• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.


    Maryland Register

    Issue Date:  September 14, 2018

    Volume 45 • Issue 19 • Pages 869—870



    Title 10 


    Notice of Proposed Action


    The Secretary of Health proposes to:

    (1) Amend Regulation .01 under COMAR 10.09.03 Pharmacy Services; and

    (2) Adopt new Regulations .01—.08 under a new chapter, COMAR 10.09.21 Pharmacists.

    Statement of Purpose

    The purpose of this action is to, in accordance with Chapters 820 and 821 of 2017:

    (1) Update the definition of pharmacist to reflect that a pharmacist’s scope of practice includes services beyond filling prescriptions; and

    (2) Establish requirements for individual pharmacists who enroll in the Program in order to counsel and prescribe certain contraceptive medications and self-administered contraceptive devices to Medical Assistance participants.

    Comparison to Federal Standards

    There is no corresponding federal standard to this proposed action.

    Estimate of Economic Impact

    The proposed action has no economic impact.

    Economic Impact on Small Businesses

    The proposed action has minimal or no economic impact on small businesses.

    Impact on Individuals with Disabilities

    The proposed action has no impact on individuals with disabilities.

    Opportunity for Public Comment

    Comments may be sent to Michele Phinney, Director, Office of Regulations and Policy Coordination, Maryland Department of Health, 201 W. Preston Street, or call 410-767-6499, or email to mphinney@maryland.gov, or fax to 410-767-6483. Comments will be accepted through October 15, 2018. A public hearing has not been scheduled.


    10.09.03 Pharmacy Services

    Authority: Health-General Article, §§2-104(b), 15-103, 15-103.1, 15-105, [and] 15-118, and 15-148(c), Annotated Code of Maryland

    .01 Definitions

    A. (text unchanged)

    B. Terms Defined.

    (1)—(30) (text unchanged)

    (31) 'Pharmacist' means an individual licensed in good standing to practice pharmacy in the state where the [prescription is filled] service is provided.

    (32)—(46) (text unchanged)


    10.09.21 Pharmacists

    Authority: Health-General Article, §2-104(b), 2-105(b), 15,-103, and 
    15-148(c), Annotated Code of Maryland

    .01 Purpose and Scope.

    This chapter establishes requirements for individual pharmacists who enroll in the Program.

    .02 Definitions.

    A. In this chapter, the following terms have the meanings indicated.

    B. Terms Defined.

    (1) “Board” means the Maryland Board of Pharmacy.

    (2) “Contraceptives” means contraceptive medications and self-administered contraceptive devices approved by the U.S. Food and Drug Administration.

    (3) “Maryland Medical Assistance Program” means the program of comprehensive medical and other health-related care for indigent and medically indigent individuals.

    (4) “Participant” means an individual who is certified as eligible for, and is receiving, Medical Assistance benefits.

    (5) 'Pharmacist' means an individual licensed in good standing to practice pharmacy in the state where the service is provided.

    (6) “Pharmacy” means an establishment or institution licensed in good standing that is required to obtain a permit in accordance with Health Occupations Article, Title 12, Annotated Code of Maryland.

    (7) “Primary care practitioner” means a licensed health care practitioner who provides an individual’s primary care services and is the primary coordinator of health care services for the individual.

    (8) “Program” means the Maryland Medical Assistance Program.

    (9) “Reproductive health care practitioner” means a licensed health care practitioner who is authorized to provide reproductive health services.

    .03 Provider Qualifications and Conditions for Participation.

    A. The pharmacist shall meet:

    (1) Licensure requirements set forth in COMAR; and

    (2) Conditions for participation set forth in COMAR

    B. A pharmacist who prescribes contraceptives shall:

    (1) Meet all Board requirements to prescribe contraceptives set forth in COMAR;

    (2) Have completed a Board-approved training program, as set forth in COMAR;

    (3) Meet all record keeping requirements set forth in COMAR; and

    (4) Meet all continuing education requirements set forth in COMAR

    .04 Covered Services.

    The following services are covered under this chapter:

    A. A patient assessment performed at the pharmacist’s practice location in order to determine:

    (1) Whether to prescribe contraceptives; and

    (2) Which contraceptive options to prescribe; and

    B. If contraceptives are prescribed, a referral:

    (1) To the participant’s primary care practitioner or reproductive health care practitioner; or

    (2) If the participant does not have a primary care practitioner or a reproductive health care practitioner, to a family planning provider or a licensed clinician who provides reproductive health care services.

    .05 Limitations.

    A pharmacist may not prescribe contraceptives before January 1, 2019.

    .06 Payment Procedures.

    A. The provider shall submit the request for payment of services rendered according to procedures established by the Department and in the form designated by the Department.

    B. The Department reserves the right to return to the provider, before payment, all invoices not properly signed, completed, and accompanied by properly completed forms required by the Department.

    C. Payment advances are not made routinely.

    D. The Program will make no direct payment to participants.

    E. Billing time limitations for claims submitted pursuant to this chapter are set forth in COMAR

    .07 Recovery and Reimbursement.

    Recovery and reimbursement are as set forth in COMAR

    .08 Cause for Suspension of Removal and Imposition of Sanctions.

    Causes for suspension or removal and imposition of sanctions are as set forth in COMAR

    Secretary of Health